Hospira (HSP) Discloses Receipt of FDA Warning Letter Following Costa Rican Facility Exploration
Tweet Send to a Friend
On August 23, 2012, Hospira, Inc. (NYSE: HSP) received a warning letter from the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
